Insider Transactions in Q2 2019 at Eli Lilly & CO (LLY)
Insider Transaction List (Q2 2019)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
87
+10.88%
|
$9,831
$113.4 P/Share
|
|
Jun 17
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
18
+0.03%
|
$2,034
$113.4 P/Share
|
|
Jun 17
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
120
+1.35%
|
$13,560
$113.4 P/Share
|
|
Jun 17
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.22%
|
$10,848
$113.4 P/Share
|
|
Jun 05
2019
|
Joshua L Smiley |
BUY
Open market or private purchase
|
Direct |
426
+1.38%
|
$50,268
$118.03 P/Share
|
|
Jun 03
2019
|
Michael J Harrington Senior VP and General Counsel |
SELL
Open market or private sale
|
Direct |
16,000
-12.67%
|
$1,856,000
$116.72 P/Share
|
|
May 20
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
171
+21.54%
|
$19,836
$116.23 P/Share
|
|
May 20
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.03%
|
$1,972
$116.23 P/Share
|
|
May 20
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+1.34%
|
$13,572
$116.23 P/Share
|
|
May 20
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
94
+0.21%
|
$10,904
$116.23 P/Share
|
|
May 03
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Open market or private sale
|
Direct |
7,577
-96.7%
|
$886,509
$117.54 P/Share
|
|
May 01
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
SELL
Payment of exercise price or tax liability
|
Direct |
6,173
-44.89%
|
$722,241
$117.04 P/Share
|
|
May 01
2019
|
Christi Shaw SVP and Pres., Lilly Bio-Meds |
BUY
Exercise of conversion of derivative security
|
Direct |
13,750
+50.0%
|
-
|
|
Apr 15
2019
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
88
+0.2%
|
$10,912
$124.08 P/Share
|
|
Apr 15
2019
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
86
+1.0%
|
$10,664
$124.08 P/Share
|
|
Apr 15
2019
|
Ellen R Marram Director |
BUY
Grant, award, or other acquisition
|
Direct |
55
+0.1%
|
$6,820
$124.08 P/Share
|
|
Apr 15
2019
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.03%
|
$1,984
$124.08 P/Share
|
|
Apr 15
2019
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
80
+15.04%
|
$9,920
$124.08 P/Share
|
|
Apr 12
2019
|
Melissa S Barnes Chief Eth/Cmpl Ofcr & SVP, ERM |
SELL
Open market or private sale
|
Direct |
4,735
-17.65%
|
$591,875
$125.15 P/Share
|
|
Apr 12
2019
|
Alfonso G Zulueta SVP & President, Lilly Int'l |
SELL
Open market or private sale
|
Direct |
10,000
-14.75%
|
$1,240,000
$124.65 P/Share
|
|
Apr 05
2019
|
Aarti S. Shah SVP & CIDO |
SELL
Open market or private sale
|
Direct |
1,800
-8.9%
|
$225,000
$125.85 P/Share
|